Sodium Polystyrene Sulfonate Oral Suspension 15G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Sodium Polystyrene Sulfonate: Oral suspension (15g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
SPS 15g/60ml Susp
Drug Image file default-drug-image.png
SPS 15g/60ml Susp
Drug Image file default-drug-image.png
Kionex 15g/60ml Susp
Drug Image file default-drug-image.png
Kionex 15g/60ml Susp
Drug Image file default-drug-image.png
SSPS 15g/60ml Susp

What is this Medicine?

SODIUM POLYSTYRENE SULFONATE (SOE dee um pol ee STYE reen SUHL fuh neyt) takes potassium out of the body by binding to it in the intestines. It is used to treat too much potassium in the body.

CVS Pharmacy Patient Statistics for Sodium Polystyrene Sulfonate: Oral suspension(15g)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

SPS 15g/60ml Suspension

NDC: 462870006
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hyperkalemia

Storage Information
Store at room temperature (between 59 to 86 degrees F)
SPS 15g/60ml Suspension

Reported Side Effects for SPS 15g/60ml Suspension

Bowel Necrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Sodium Polystyrene Sulfonate

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit
your own observations and experiences to benefit others.